Harry M Jansen Kraemer Jr
CIK 1082877 · Director · last filed 2026-10-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
OPCH price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
13320 BALLANTYNE CORPORATE PLACE
CHARLOTTE, NC 28277
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LDOS | Director | 225,389 | $139.64 | $31.47M | -$1.05M | 96 | 2026-10-09 |
| OPCH | Director | 458,997 | $31.29 | $14.36M | $8.50M | 16 | 2026-05-22 |
| XRAY | Director | 148,351 | $9.35 | $1.39M | -$1.69M | 49 | 2024-01-16 |
| Option Care Health, Inc. (BIOS) Delisted | Director | 87,910 | $10.79 | $949.0K | $0 | 1 | 2019-12-11 |
| VWR Corp (VWR) Delisted | Director | 0 | — | — | $0 | 4 | 2017-11-22 |
| SIRONA DENTAL SYSTEMS, INC. (SIRO) Delisted | Director | 0 | — | — | $0 | 9 | 2016-03-01 |
| Catamaran Corp (CTRX) Delisted | Director | 0 | — | — | $1.05M | 9 | 2015-07-23 |
| Leidos Holdings, Inc. (SAI) Delisted | Director | 98,143 | $0.75 | $73.6K | -$483.1K | 48 | 2013-08-01 |
Recent Filings · Page 4 of 24
233 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-05-07 | LDOS | Grant (A) | +912 | $0 | EDGAR |
| 2024-05-03 | LDOS | Mixed | +3,013 | -$60 | EDGAR |
| 2024-04-30 | LDOS | Grant (A) | +17 | $0 | EDGAR |
| 2024-04-01 | LDOS | Grant (A) | +362 | $0 | EDGAR |
| 2024-02-28 | OPCH | Buy (P) | +35,000 | $1.10M | EDGAR |
| 2024-01-16 | XRAY | Grant (A) | +46 | $0 | EDGAR |
| 2024-01-03 | LDOS | Grant (A) | +436 | $0 | EDGAR |
| 2024-01-02 | XRAY | Grant (A) | — | $0 | EDGAR |
| 2023-10-16 | XRAY | Grant (A) | +74 | $0 | EDGAR |
| 2023-10-03 | LDOS | Grant (A) | +482 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.